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Abstract
Objective: Working through a depressive illness can improve mental health but also carries risks and costs from reduced
concentration, fatigue, and poor on-the-job performance. However, evidence-based recommendations for managing work
attendance decisions, which benefit individuals and employers, are lacking. Therefore, this study has compared the costs
and health outcomes of short-term absenteeism versus working while ill (‘‘presenteeism’’) amongst employed Australians
reporting lifetime major depression.
Methods: Cohort simulation using state-transition Markov models simulated movement of a hypothetical cohort of workers,
reporting lifetime major depression, between health states over one- and five-years according to probabilities derived from
a quality epidemiological data source and existing clinical literature. Model outcomes were health service and employment-
related costs, and quality-adjusted-life-years (QALYs), captured for absenteeism relative to presenteeism, and stratified by
occupation (blue versus white-collar).
Results: Per employee with depression, absenteeism produced higher mean costs than presenteeism over one- and five-
years ($42,573/5-years for absenteeism, $37,791/5-years for presenteeism). However, overlapping confidence intervals
rendered differences non-significant. Employment-related costs (lost productive time, job turnover), and antidepressant
medication and service use costs of absenteeism and presenteeism were significantly higher for white-collar workers. Health
outcomes differed for absenteeism versus presenteeism amongst white-collar workers only.
Conclusions: Costs and health outcomes for absenteeism and presenteeism were not significantly different; service use
costs excepted. Significant variation by occupation type was identified. These findings provide the first occupation-specific
cost evidence which can be used by clinicians, employees, and employers to review their management of depression-
related work attendance, and may suggest encouraging employees to continue working is warranted.
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Introduction
The economic cost of depression is largely due to related work
impairment, disability [1], and lost productivity from sickness
absenteeism and presenteeism (continuing to work when ill) [2].
Presenteeism is common [3], more costly than absenteeism [3,4],
and may account for up to 80% of depression-related lost
productive time [2]. Internationally, this equates to an estimated
35.7 billion USD [2], 15.1 billion UK pounds [5] and 12.6 billion
Australian dollars [6] annually. However, the health outcomes of
presenteeism are less established [7]. Although presenteeism has
been shown to increase the incidence of serious coronary events
[8], and predict poor self-rated health [9] and future sickness
absence [10], it may also confer health benefits via supervisor or
colleague support and a maintained daily routine [11]. In fact, its
potential health benefits may outweigh any negative health
outcomes and economic costs.
Evidence regarding the economic costs and health benefits of
absenteeism and presenteeism is essential to inform the design of
workplace depression management strategies [12], particularly
those focused on promotion and prevention. At present, the right
balance between absenteeism and presenteeism for employees with
depression is unknown. Therefore, current clinical practice
guidelines for employers or employees seeking informed advice
about when continued work attendance is optimal are lacking.
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Further, despite awareness that work characteristics and demands
can influence employee attitudes to work attendance or render
them either unable or reluctant to take time off when sick [13],
evidence of whether the costs and health consequences of
absenteeism and presenteeism differ by occupation is scarce.
Therefore, it is unclear whether work attendance recommenda-
tions should be tailored to different job types.
This study used population level data and a Markov cohort
simulation approach to compare the costs and health outcomes of
working while ill versus work absence over time amongst
employed Australians reporting lifetime major depression. The
model was amended to quantify variations across occupation (blue
vs. white collar). With the information provided this study aimed
to: i) determine whether continuing to work when ill or taking a
planned, short-term sickness absence is the more cost-effective
decision for employees reporting depression; and ii) determine
whether subsequent recommendations should be altered by
occupation type.
Method
Definition of scenarios and type of Analysis
We conducted an epidemiologic-based, analytic modelling
study, using cohort simulation and a state-transition Markov
model, to compare the costs and health outcomes of working while
experiencing depression versus taking a sickness absence. The
decision analysis approach used in this study requires presenteeism
and absenteeism to be defined as mutually exclusive scenarios.
Presenteeism, was therefore defined as the absence of absenteeism,
consistent with previous approaches [8]. In other words, no
reported depression-specific, work- and role-functioning disability
days in response to the NSMHWB depression module item
‘‘About how many days out of 365 in the past 12 months were you
totally unable to work or carry out your normal activities because
of your (sadness/or/discouragement/or/lack of interest)?’’. Ab-
senteeism, was the converse. Therefore, this analysis is based on
two assumptions; a) all employed individuals with 12-month
depression will experience impairment relevant to their work; and
b) the categories of 12-month absenteeism and presenteeism are
mutually exclusive. This method was selected as it provides a
measure of depression-specific disability days and therefore
removes the possible influence of co-morbid disorders of work
attendance decisions.
Two subsequent models determined whether outcomes differed
for blue- versus white-collar workers. All models were identically
structured and generated using Data TreeAge Pro software
(Williamstown, Mass.). Cohort simulation was deemed appropriate
as it synthesises best available evidence to address difficult-to-
answer questions, and is ideal when experimental trials are not
ethical or feasible. Cohort simulation is commonly used in health
economics, and related clinical and epidemiological research, to
model future costs and outcomes of patients, groups or populations
under alternative scenarios such as different treatment options [25]
and is unique in that it is able to predict cross-sectional data and
simulate life courses of people, providing longitudinal outcomes. A
wide range of evidence is usually included, such as epidemiologic
surveys, meta-analyses, and high-quality single studies in order to
determine the benefits and costs beyond time horizon of existing
data [26][37].
Analytic Structure and Time Horizon
A hypothetical cohort of employees (N=1000) occupied and
moved between seven health states over time according to
probabilities (Figure 1) [14]. A 3-month cycle length was chosen
to reflect the natural history of depression, and the selected health
states are clinically relevant and informed by related research [14].
Where relevant, health states were assigned lost productive time,
job turnover, and health service use costs, and a utility value
consistent with a depression diagnosis (depressed/not depressed)
and treatment status (in treatment/not in treatment). The number
of people and the amount of time they spent in each health state
determined the aggregate costs and health outcomes at the
conclusion of the model. Costs and health outcomes were
considered from the societal perspective over 1-year, and extended
to a 5-year time horizon to produce results relevant to employers’
decision-making time frames i.e. those interested in improving
outcomes for their current employees.
Data Sources
Probabilities and costs were derived from our primary
epidemiological data source, the National Survey of Mental
Health and Wellbeing (2007) (NSMHWB) [15], or published
literature. The NSMHWB is a stratified, random household
survey conducted by the Australian Bureau of Statistics (ABS) to
determine lifetime and 12-month prevalence estimates of affective
and other common psychiatric disorders within the Australian
population. To estimate the prevalence of specific mental
disorders, the NSMHWB used the World Mental Health Survey
Initiative version of the World Health Organization’s Composite
International Diagnostic Interview, version 3.0 (WMH-CIDI 3.0).
This is a comprehensive interview used to assess the lifetime, 12-
month, and 30-day prevalence of selected mental disorders by
measuring symptoms and their impact on day-to-day activities. It
provides an assessment of mental disorders based on the
definitions and criteria of two classification systems: the Diagnostic
and Statistical Manual of Mental Disorders, Fourth Edition
(DSM-IV); and the WHO International Classification of Diseases,
Tenth Revision (ICD-10). Both the DSM-IV and the ICD-10 have
sets of criteria, necessary for diagnosis, which specify the nature
and number of symptoms required, the level of distress or
impairment required, and the exclusion of cases where symptoms
can be attributed to general medical conditions, such as a physical
injury, or to substances, including alcohol. The WMH-CIDI 3.0
was also used to collect information on the course, onset, recency
and persistence of symptoms of mental disorders, the impact of
mental disorders on home, work, relationship and social function-
ing, and treatment seeking and access to adequate treatment.
The NSMHWB received a response rate of 60% (N=8841) and
data were weighted to represent the projected Australian adult
population (N= 16 015 300) thus ensuring the data and findings
derived from this survey are generalisable to the total in scope
population. More specifically, weighting adjusts results from a
sample survey to infer results for the total in-scope population by
allocating a ‘weight’ to each sample unit corresponding to the level
at which population statistics are produced, e.g. household or
person level. This weight is considered an indication of how many
population units are represented by the sample unit. ABS
household surveys are calibrated to population benchmarks by
state, part of state, age and sex. Initial person weights were
simultaneously calibrated to population benchmarks for state by
part of state, age, sex, state by household composition, state by
educational attainment, and state by labour force status. House-
hold weights were derived by separately calibrating initial
household selection weights to the projected household composi-
tion population counts of households containing persons aged 16–
85 years, who were living in private dwellings in each state and
territory of Australia, at 31 October 2007.
Comparing the Costs and Health Outcomes of Working When Ill
PLOS ONE | www.plosone.org 2 September 2014 | Volume 9 | Issue 9 | e105430
Occupation type was derived from the employment component
of the NSMHWB, which was summarised according to the
Australian and New Zealand Standard Classification of Occupa-
tion (ANZSCO) [16]. Data from published studies determined the
probability [17] and cost [18] of depression-related job turnover,
mean presenteeism days [19], and absenteeism and presenteeism-
related lost productive time costs [2,20].
Initial Probabilities
The NSMHWB provided the major depression diagnosis used
to distribute the cohort among health states (Figure 1), and the
reported depression-specific disability days used to determine
distribution between absenteeism and presenteeism scenarios. The
probability of being in each of the health states for a hypothetical
white or blue collar worker reporting absenteeism are presented in
Table S2, initial probabilities for white and blue collar workers
reporting presenteeism are presented in Table S3. (see Tables S1,
S2, S3) [21]. Models only included individuals with depression, as
determined by current 12-month symptoms or any lifetime
experience. Individuals were defined as ‘depressed’ if they reported
12-month depression symptoms, or ‘recovered’ if they reported
lifetime depression without 12-month symptoms. ‘In treatment’
referred to self-reported contact with a health professional for a
mental health problem any time in the last 12-months [15].
Individuals started the simulation process in a ‘depressed’ or a
‘recovered’ state (Figure 1).
Transition Probabilities
Transition probabilities were derived from relevant secondary
sources (see Table S1, S2, S3), applied in each successive 3-month
cycle, and governed the cohort’s movement between health states
over time (see Table S1, S2, S3). Tables S1, S2 and S3
demonstrate how they differed according to occupation type
(Table S1, S2, S3). Remission (with and without treatment)
determined movement from a ‘depressed’ to a ‘recovered’ state,
and relapse (with and without treatment) was the converse. The
transition probabilities were derived from published findings from
a national survey of the US population [2,4], (see Table S1) in
which diagnoses were made using the Primary Care Evaluation of
Mental Disorders (PRIME-MD) instrument. The PRIME-MD has
been shown to have excellent agreement with clinical diagnoses
made using the lengthier diagnostic interviews such as the CIDI
[35,36]. Treatment initiation probabilities determined movement
from a ‘not in treatment’ to an ‘in treatment’ state. Age- and sex-
specific mortality/survival rates determined movement to the
‘deceased’ state. All depression states had an increased mortality
rate due to risk of suicide, and an increased risk of early retirement
(before the age of 50). The deceased and retirement health states
were absorbing states, which individuals could not leave once
entered.
Figure 1. State transition Markov model diagram.
doi:10.1371/journal.pone.0105430.g001
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Costs
Lost productive time, job turnover, depression-related service
use and antidepressant medication costs were assigned to each
health state (see Table S1, S2, S3). They were based on the
probability of various cost-incurring events being experienced, the
number of times that event occurred, and the unit cost assigned to
that event. All costs were in 2007 Australian dollars (AUD), to
reflect the reference year of the NSMHWB. Lost productive time
costs involved multiplying the number of depression-specific
absenteeism and presenteeism days, adjusted to a 3-month
estimate, by the average daily wage. Daily wage, weekly wage
and annual salary were calculated using the Australian Bureau of
Statistics estimates of employee earnings and hours averaged
across all occupations, and blue collar and white collar occupa-
tions separately, as defined by ANZSCO [16]. Depression-related
job turnover costs included the recruitment, hiring and training
costs of replacing an employee who is terminated or voluntarily
leaves. The job turnover probability estimate, although deemed
the best available [22], was from a sample considered unrepre-
sentative of the general population. Therefore, probabilities were
restricted to ‘depressed in treatment’ states [17]. The NSMHWB
provided depression-specific service use and antidepressant med-
ication costs. Number of contacts in the past year with general
practitioners, psychologists, psychiatrists, mental health nurses and
alternative therapists were costed using Australia’s national health
insurance scheme information (the Medicare Benefits Schedule).
Reported 2-week antidepressant medication use was converted to
3-month probability estimates. As the type/s of antidepressant
used, and duration and dosage were unknown, prescriptions were
costed for 3-months using the medication type (Selective Serotonin
Reuptake Inhibitors) and dosage recommended under optimal
care [23].
Health Outcomes
Quality-adjusted life years (QALYs), a combination of quality
(measured using utilities) and duration of life, were the primary
measure of health outcome (see Table S1, S2, S3). Utilities are a
global measure of the value attached to each health state and ideal
to capture the broad effects on health and wellbeing possible from
presenteeism and absenteeism [7,8]. The applicability of utility-
weighted, population health outcomes to depression has been
demonstrated [24]. The NSMHWB [15] provided utilities derived
from the Assessment of Quality of Life-4D (AQoL-4D) [25], a
validated measure, able to detect subtle quality-of-life differences
in areas including mental health [26].
Sensitivity Analysis
Probabilistic sensitivity analysis using Monte Carlo simulation
determined the total costs and health outcomes of all models.
Values for all model parameters were sampled from specified
distributions. These were beta distributions for probabilities,
gamma distributions for costs and uniform distributions when
true functional form was unknown as recommended by published
guidelines for decision modelling in health economic evaluation
[27]. Expected costs and health outcomes were calculated for a
hypothetical cohort of 1000 workers. Re-sampling from each
distribution and recalculating the costs and health outcomes from
the model generated a distribution of the estimated values. 95%
credible intervals were estimated from the simulated data. Costs
and QALYs were both discounted at 3% [14,28].
Univariate sensitivity analysis was performed by varying single-
parameter values according to credible ranges, informed by
existing literature, and re-running the model. Parameters selected
for further investigation were those most likely to influence
differences in cost; probability and cost of job turnover, daily wage
and annual salary. Daily wage, weekly wage, and annual salary
were replaced with identical values for blue- and white-collar
workers to explore whether observed differences between the
groups were due to white-collar workers’ higher mean wage. Job
turnover cost, represented in both models by a large range of
0.75–1.5 times a worker’s annual salary, was widened further to
represent the full range of estimates reported in the literature; 0.5–
10 times a worker’s annual salary. Job turnover probability for
workers experiencing depression was increased from 10.5% to




Table 1 presents mean costs and health outcomes for absen-
teeism and presenteeism over one-year with 95% credible
intervals. Outcomes are presented for the base case, and blue-
and white-collar models. The 1-year total mean cost of absentee-
ism per employee with depression was $9626, presenteeism costs
were $7864. While total costs and all cost contributors (job
turnover costs, lost productive time, antidepressant medication
and service use) were higher for absenteeism reporters than
presenteeism, the only significant difference was for service use
costs (Table 2). One-year health outcomes did not significantly
differ for absenteeism reporters relative to presenteeism reporters,
based on overlapping 95% credible intervals (Table 1).
Five-year total simulated costs per worker for absenteeism were
$42 573 (95% CI: $19 269–$69 348), presenteeism costs ($37 791,
95% CI $17 475–$66 781) were not significantly different.
Further, 5-year health outcomes did not significantly differ for
absenteeism (2.70 QALYS; 95% CI 2.16–3.57) compared to
presenteeism reporters (3.14 QALYs; 95% CI 2.34–3.75).
Blue- and White-collar Models
One-year total simulated cost of absenteeism was $6223 per
blue-collar worker and $12 938 per white-collar worker (Table 1).
Over 1-year, presenteeism cost an estimated $5370 per blue-collar
worker and $11 178 per white-collar worker. Job turnover, lost
productive time, antidepressant medication and depression-related
service use costs were all significantly higher for white-collar
workers (Table 2).
While not significantly different, blue-collar workers reporting
absenteeism showed a trend towards better 1-year health
outcomes (0.57 QALYs; 95% CI 0.51–0.60) compared to white-
collar absenteeism reporters (0.54 QALYs; 95% CI 0.49–0.56).
Similarly, blue-collar presenteeism reporters had slightly better
health outcomes (0.65 QALYs; 95% CI 0.58–0.66) when
compared to white-collar presenteeism reporters (0.66 QALYs;
95% CI 0.60–0.71) (Table 1). Within the white collar workforce,
presenteeism reporters had significantly better quality of life (0.66
QALYs) compared to white collar workers who reported
absenteeism (0.54 QALYs). There were no differences in health
outcomes for blue collar workers reporting absenteeism versus
presenteeism.
The simulated costs and health outcomes of absenteeism and
presenteeism over 5-years differed for blue- versus white-collar
workers. Five-year total simulated cost of absenteeism was $26 401
per blue-collar worker and $63 771 per white-collar worker.
Presenteeism costs were estimated at $23 711 per blue-collar and
$54 709 per white-collar worker. Five-year health outcomes did
not significantly differ for blue-collar workers reporting absentee-
ism (2.74 QALYs) compared to white-collar absenteeism reporters
Comparing the Costs and Health Outcomes of Working When Ill
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(2.64 QALYs). Nor did they differ for blue-collar presenteeism
reporters (3.12 QALYs) when compared to white-collar presentee-
ism reporters (3.20 QALYs).
Sensitivity Analysis
Probabilistic sensitivity analysis revealed wide 95% credible
intervals around the cost of job turnover for blue-collar and white-
collar workers, by absenteeism and presenteeism, for both time
frames (Table 2). This highlights the importance of job turnover in
terms of its contribution to the overall cost of the models and the
need for a more robust estimate.
Base case results revealed 1-year absenteeism costs ranged from
$7376–$46 273 per worker (Table 3). In the occupation-specific
models 1-year absenteeism costs of ranged from $5075–$22 186
per blue-collar worker, and $9783–$57 740 per white-collar
worker (Table 3). Over 1-year, base case presenteeism costs varied
from $5500–$46 377. Further, presenteeism costs ranged from
$4349–$19 864 per blue-collar worker, and $9783–$55 672 per
white-collar worker (Table 3). Using a uniform daily wage and
annual salary estimates revealed differences in cost outcomes
between blue- and white-collar workers remained i.e. total cost
was higher for white-collar workers. Varying cost of job turnover
estimates for workers with and without depression symptoms had
the most substantial impact on total cost outcomes (Table 4).
Table 1. One-year cost and health outcomes of absenteeism and presenteeism.
Absenteeism Presenteeism
Estimate 95% Credible Interval Estimate 95% Credible Interval
Blue Collar
Cost ($ AUD) 6223 4722–5997 5370 5589–6833
QALYs 0.57 0.51–0.60 0.65 0.58–0.66
White Collar
Cost ($ AUD) 12 938 11 442–14 416 11 178 9662–12 764
QALYs 0.54 0.49–0.56 0.66 0.60–0.71
Base Case
Cost ($ AUD) 9626 6224–11 384 7864 4452–9565
QALYs 0.60 0.40–0.84 0.68 0.48–0.89
doi:10.1371/journal.pone.0105430.t001
Table 2. One year costs of absenteeism and presenteeism.
Absenteeism Presenteeism
Cost ($ AUD) 95% CIs Cost ($ AUD) 95% CIs
Blue Collar
Lost Productive Time 2738 2693–2741 1762 1731–1764
Job Turnover 3456 2899–4055 3586 2964–4173
Service Use 2 1–4 0.16 0.06–0.24
Antidepressants 36 7–46 20 6–45
Total 6223 6326–8048 5370 4522–5952
White Collar
Lost Productive Time 4070 3995–4075 2198 2158–2201
Job Turnover 8745 7225–10138 8880 7330–10 431
Service Use 16 6–32 4 2–5
Antidepressants 106 104–106 87 85–88
Total 12 938 11 442–14 416 11 178 9662–12764
Base Case
Lost Productive Time 3095 1945–4457 2032 1308–2680
Job Turnover 6305 3633–7783 5692 2518–7358
Service Use 45 20–62 11 8–14
Antidepressants 179 124–172 128 112–153
Total 9626 6224–11 384 7864 4452–9565
doi:10.1371/journal.pone.0105430.t002
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Alternative Parameters 7864 9626
Probability of Job Turnover
Not Depressed 0.025
0.05 11 899 13 464
0.075 12 627 13 530
Depressed 0.105
0.25 9886 12 796
0.50 13 351 18 230
Cost of Job Turnover
Not Depressed 512 5500 7376
1154
11 615 46 377 46 271
Depressed 2080 7061 8634
4685
47 318 20 997 25 674
doi:10.1371/journal.pone.0105430.t003
Table 4. Absenteeism and presenteeism cost outcomes of selected one-way sensitivity analysis over one-year.
Blue Collar White Collar
Presenteeism Absenteeism Presenteeism Absenteeism





11 178 12 938
Probability of Job
Turnover
Not Depressed 0.01 0.025
0.02 7 170 8036 0.05 16 533 18 331
0.05 12 627 13 530 0.06 18 733 20 545
Depressed 0.105 0.105
0.25 7823 8474 0.25 15 728 17 235
0.50 12 019 12 332 0.50 23 527 24 598
Cost of Job Turnover
Not Depressed 223 4349 5195 717 8044 9783
502 1614
4470 19 864 20 818 14 348 55 672 57 740
Depressed 2303 4395 5075 2912 9373 10 843
5183 6553
46 079 19 167 22 186 38 254 26 889 31 478
Income
Mean Annual Salary 44 252 55 595
72 517 7660 8431 72 517 13 811 15 529
Daily Wage 170 215
279 6506 7988 279 11 839 14 162
doi:10.1371/journal.pone.0105430.t004
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Discussion
The purpose of this analysis was to estimate the costs and health
outcomes of absenteeism versus presenteeism for employed
Australians experiencing major depression, and quantify variations
across occupation. Within blue and white-collar groups, absen-
teeism reporters incurred significantly higher lost productive time,
service use, and antidepressant medication costs than presenteeism
reporters. Differences in lost productive time costs may be
attributable to absenteeism reporters taking time off work due to
more severe symptoms, which may also account for their greater
antidepressant medication and service use, and the related costs.
These findings suggest to employers and health professionals that
absenteeism reporters should be the more immediate focus of any
health promotion strategies implemented in the workplace.
However, whilst presenteeism costs were often lower than
absenteeism costs, they were also substantial, thus indicating the
need to better manage this behavior to prevent depression-related
productivity loss. Although, not significant, the higher QALYs of
employees reporting presenteeism suggests they may be milder
depression cases, and their work capacity is reduced but not
eliminated. Therefore, employers and health professionals could
collaborate to rearrange job tasks to suit employees’ abilities [1],
and/or provide flexible work attendance arrangements to make
the most of employees’ work capacity whilst allowing time off
when productivity contributions are more severely affected.
Graded sickness absence, which allows employees to work part-
time, work full-time hours but perform modified tasks, or perform
regular tasks with reduced input whilst receiving a partial sick
leave pay and partial salary [29], has been proven effective at
keeping people with reduced work ability in working life [30,31].
Such an approach may have positive effects on health and well-
being through the maintenance of their daily routines, and by
providing a sense of purpose and opportunities for social support
from co-workers. Recognition of reduced capacity may also
alleviate stress on the affected worker and improve relationships
with co-workers by enabling better planning of how tasks may
need to be allocated. To ensure the efficacy of such programs,
complementary efforts to reduce stigma associated with mental
health issues are required as modifying duties or work-time
arrangements may expose employees to the negative effects of
stigma and exacerbate their condition [32].
As lost productive time was valued on the basis of mean wage,
wage differences between blue- and white- collar workers partly
account for the differences by occupational type in overall costs.
When a white-collar worker reports depression-related absentee-
ism or presenteeism the ensuing productivity loss is greater as their
time is valued more highly within the labour market. Whilst
sensitivity analyses revealed a higher mean wage does not entirely
explain the observed differences, it explains the work-related
variation, and demonstrates to managers and policy makers the
importance of tailoring workplace intervention and promotion
strategies to specific occupation types. In particular, employers of
white-collar workers, particularly those with paid sick leave
entitlements, for whom reducing depression-related absenteeism
and presenteeism within this group would have significant cost-
saving potential. However, as wages fully explain the aforemen-
tioned differences in work-related costs, from a workplace
perspective, strategies designed to ameliorate depression-related
absenteeism and presenteeism amongst blue-collar workers are
equally important.
Higher service use and antidepressant medication costs for
white-collar workers may be partly explained by the sex
distribution between occupation types in our sample. That is,
the combination of women being more likely to disclose depression
symptoms and seek treatment [33], and the fact that 85% of
females in our sample were white-collar workers, may have
increased service-related costs within the white-collar group. This
is relevant for managers and employers with a large proportion of
female staff, such as those operating in the retail, education, or
health sectors. However, these are societal costs and workplace
mental health support could have broader benefits beyond specific
organisations or work settings. Therefore, investment in the
mental health and wellbeing of the workforce should be seen as
priority for society in general as well employers.
Disparate health outcomes between occupation groups, suggest
depression and related work attendance decisions affect blue and
white-collar workers differently. White-collar absenteeism report-
ers experienced poorer QALYs than their blue-collar counterparts
and depression-related absenteeism and presenteeism costs were
higher for white collar workers. This may help to identify areas of
priority in regards to mental health promotion and prevention. In
particular, the costs associated with absenteeism for white-collar
workers, borne by employers via lost productive time and by
employees via service use and antidepressant medication costs,
suggest they are an important focus of future workplace health
promotion strategies with the potential to deliver individual and
societal benefits.
Limitations
Lower QALYs amongst absenteeism compared to presenteeism
reporters may be due to absenteeism reporters experiencing more
severe symptoms which restrict their work ability and impact
quality-of-life. However, whether presenteeism reporters have
higher QALYs due to benefits of continued work attendance, or
whether continuing to work is due to higher quality-of-life,
remains unclear. Analysis of absenteeism versus presenteeism costs
and health outcomes stratified by severity of depression may allow
recommendations as to whether presenteeism is advisable, and
whether absenteeism reporters should be encouraged to return to
work promptly. The inability to source each model input stratified
by depression severity status precluded such an analysis being
conducted and was one of this study’s major limitations.
Further, job turnover was the largest contributor to overall cost,
but sensitivity analysis revealed the probability and cost estimates
for job turnover used had substantial uncertainty around them;
95% credible intervals were wide. Additionally, potentially
relevant costs, including those attributable to depression-related
workplace accidents, were excluded due to inability to find a
reliable estimate which met established quality of evidence criteria
[22]. Exploratory sensitivity analysis revealed workplace accidents
costs contributed substantially to total cost and future effort should
be directed at understanding the magnitude of this problem.
Presenteeism behaviour was defined in the initial scenarios as
the absence of depression-related absenteeism in the 12-months
prior to the NSMHWB interview. This initial classification
assumes that the categories of 12-month absenteeism and
presenteeism were mutually exclusive, which is not always correct.
Recent research has identified that episodes of absenteeism are
often preceded and followed by episodes of presenteeism [38].
This highlights that employed individuals reporting depression can
experience both absenteeism and presenteeism within a given
period of time. Therefore there may be some error in classification
at baseline based on this definition. However, while there was a
NSMHWB item which asked respondents to report the number
disability, or presenteeism, days they experienced in the past year,
separate to an item which asked individuals to report their number
of absence days, it was not depression specific. Therefore, although
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the method we employed to define presenteeism may be
considered a limitation, it was depression-specific and removed
the possible influence of co-morbid disorders on work attendance
decisions. Further, as we modelled what happened to our
hypothetical cohort in 3-month cycles, individuals were assigned
probabilities of lost productive time based on both absenteeism
and presenteeism as we know they move in and out of these states
over time.
Absenteeism reporters had lower QALYs, albeit not significant-
ly, compared to presenteeism reporters. This may be due to
individuals reporting absenteeism experiencing more severe
symptoms which restrict their work ability and by extension their
quality-of-life. However, what remains unclear is whether individ-
uals reporting presenteeism have higher quality-adjusted life years
due to benefits of continued work attendance such as social
support, structured routine and income or whether continuing to
work is due to higher quality-of-life. This highlights the need for
longitudinal data examining the impact of continued work
attendance not only on Quality of Life amongst employed
individuals reporting depression, but also whether any observed
changes are as a result of their changes in the severity of their
depression. Such data would enable further exploration s of
absenteeism versus presenteeism costs and health outcomes
stratified by severity of depression, and may allow recommenda-
tions as to whether continuing to work is advisable and whether
absenteeism reporters should be encouraged to return to work as
soon as possible. The inability to source individual model inputs
stratified by depression severity status precluded such an analysis
being conducted in the present study.
Strengths
This study’s most notable strength was the use of a quality
epidemiological data source providing representative estimates of
the Australian working population [15]. This allows generalizabil-
ity of our findings and facilitates their translation to all employed
Australians. Another strong point is the major depression
diagnoses provided by the NSMHWB, determined using the
modified version of the World Mental Health Survey Initiative
version of the Composite International Diagnostic Interview
(WMH-CIDI). This instrument has undergone extensive method-
ological testing and development which ensures the international
comparability of our results. Additionally, occupation type is an
objectively measured variable which eliminates the potential for
answers regarding working characteristics to be influenced by
response style (acquiescence, social desirability), personality
characteristics and negative affect [34]; an important consider-
ation within a sample of individuals experiencing depression.
Conclusion
These findings could inform workplace health promotion
strategies aimed at improving the management of depression
and related work attendance behaviour, and benefit employees,
employers and broader society via investment in a healthy and
productive workforce. Informing employers and health care
professionals of the health and economic benefits of presenteeism
for employees experiencing depression could encourage them to
adapt work environments, allow employees to perform modified
tasks, and offer flexible work time arrangements to promote
continued work attendance [29]. Such action may decrease
productivity loss, as employers use their employees’ remaining
work ability more effectively, and reduce turnover and employee
replacement costs as employees with depression continue to be
productive members of the workforce [30]. Secondly, and of
interest to health professionals, such workplace modifications may
have positive, long-term effects on health and well-being via
maintained daily routine and co-worker support. Finally, the
exploration of these outcomes by occupation type allows work
attendance recommendations to be tailored to specific occupation
types. Such information may be of particular importance for
specific occupations or sectors with strong attendance demands
such as small businesses, who lack the human capital to
compensate for the lost productivity associated with absenteeism,
or health care professionals with difficult to substitute skills.
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